← Open Payments lookup

SHARON WERTH: Open Payments

NPI 1093390635 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$671 in 37 payments from 10 companies in 2025. Trend: 2023 $724 · 2024 $467 · 2025 $671

Food & beverage: $671
CompanyPaymentsAmount
Novo Nordisk Inc13$209
Amgen Inc.10$187
Axsome Therapeutics, Inc.3$89
ABBVIE INC.3$58
PFIZER INC.2$34
GlaxoSmithKline, LLC.2$30
Otsuka America Pharmaceutical, Inc.1$18
ABIOMED1$17
Teva Pharmaceuticals USA, Inc.1$15
Bayer Healthcare Pharmaceuticals Inc.1$14

Products named: REPATHA, Rybelsus, Wegovy, Symbravo, Ozempic, OTEZLA, UBRELVY, ELIQUIS.

Industry payments across TX — which companies pay providers there.